Act Now: Protect Your Investment – Rosen National Trial Lawyers Urges Fulcrum Therapeutics Inc. Shareholders to Seek Legal Representation Before Critical Deadline in Securities Class Action Lawsuit
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FULC NEW YORK, May 27, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022…